Global Innovative Platforms (GIPL) Cash from Operations Growth (1y) (2022 - 2026)
Powered by 
Analysis
Global Innovative Platforms (GIPL) Cash from Operations Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 86.90% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 8.26% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 16.88% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 13.27% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 27.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.52% |
| Mar 31, 2026 | 254.29% |
| Dec 31, 2025 | -66.03% |
| Sep 30, 2025 | -26.59% |
| Jun 30, 2025 | -41,780.23% |
| Mar 31, 2025 | 7,907.80% |
| Dec 31, 2024 | -1,985.36% |
| Sep 30, 2024 | -167.99% |
| Jun 30, 2024 | 96.78% |
| Mar 31, 2024 | 95.80% |
| Dec 31, 2023 | 70.39% |
| Sep 30, 2023 | -299.13% |
| Jun 30, 2023 | -18.72% |
| Sep 30, 2022 | 66,448.98% |
| Jun 30, 2022 | -122.47% |